IMCR
Immunocore Holdings plc
NASDAQ · Healthcare · Biotechnology · GB
$36.13
−3.83%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+29.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | Ratcliffe Peter John · director | A-Award | 27,492 | $29 |
| May 28, 2026 | Peterson Kristine · director | A-Award | 27,492 | $29 |
| May 28, 2026 | Pao William · director | A-Award | 27,492 | $29 |
| May 28, 2026 | Kaul Siddharth · director | A-Award | 27,492 | $29 |
| May 28, 2026 | Bell John Irving · director | A-Award | 27,492 | $29 |
| May 28, 2026 | Herbst Roy Steven · director | A-Award | 27,492 | $29 |
| Feb 19, 2026 | Coy Travis Alan · officer: Chief Financial Officer | A-Award | 95,637 | $32 |
| Feb 19, 2026 | Coy Travis Alan · officer: Chief Financial Officer | A-Award | 33,353 | $0.00 |
| Feb 19, 2026 | Jallal Bahija · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 23,817 | $0.00 |
| Feb 19, 2026 | Jallal Bahija · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 11,474 | $32 |
| Feb 19, 2026 | St Leger Tina Amber · officer: CHIEF HR OFFICER | M-Exempt | 2,119 | $0.00 |
| Feb 19, 2026 | GOLL JOHN · officer: SVP, FINANCE & CAO | A-Award | 7,411 | $0.00 |
| Feb 19, 2026 | GOLL JOHN · officer: SVP, FINANCE & CAO | Sale | 698 | $32 |
| Feb 19, 2026 | GOLL JOHN · officer: SVP, FINANCE & CAO | M-Exempt | 1,351 | $0.00 |
| Feb 19, 2026 | Jallal Bahija · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 88,573 | $0.00 |
| Feb 19, 2026 | Jallal Bahija · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 395,066 | $32 |
| Feb 19, 2026 | Berman David M · officer: HEAD OF R&D | Sale | 5,965 | $32 |
| Feb 19, 2026 | Berman David M · officer: HEAD OF R&D | M-Exempt | 11,824 | $0.00 |
| Feb 19, 2026 | St Leger Tina Amber · officer: CHIEF HR OFFICER | Sale | 1,000 | $32 |
| Feb 19, 2026 | GOLL JOHN · officer: SVP, FINANCE & CAO | A-Award | 21,252 | $32 |
| Dec 8, 2025 | Berman David M · officer: HEAD OF R&D | Sale | 572 | $40 |
| Dec 8, 2025 | Berman David M · officer: HEAD OF R&D | Sale | 31,341 | $40 |
| Dec 8, 2025 | Berman David M · officer: HEAD OF R&D | M-Exempt | 572 | $17 |
| Dec 8, 2025 | Berman David M · officer: HEAD OF R&D | M-Exempt | 31,341 | $17 |
| Dec 1, 2025 | Berman David M · officer: HEAD OF R&D | M-Exempt | 5,521 | $17 |
| Dec 1, 2025 | Berman David M · officer: HEAD OF R&D | M-Exempt | 69,404 | $17 |
| Dec 1, 2025 | Berman David M · officer: HEAD OF R&D | Sale | 5,521 | $40 |
| Dec 1, 2025 | Berman David M · officer: HEAD OF R&D | Sale | 69,404 | $40 |
| Nov 26, 2025 | Berman David M · officer: HEAD OF R&D | Sale | 18,020 | $40 |
| Nov 26, 2025 | Berman David M · officer: HEAD OF R&D | Sale | 100 | $40 |
Institutional positioning
13F filings over the trailing two quarters
New 49Increased 102Reduced 89Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 5,721,945 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 4,869,798 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 4,869,798 | Aug 14, 2026 |
| FMR LLC | Increased | 4,829,154 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4,706,168 | May 15, 2026 |
| FMR LLC | Reduced | 4,307,246 | Aug 13, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 3,693,241 | May 11, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 3,638,241 | Aug 14, 2026 |
| BELLEVUE GROUP AG | Unchanged | 2,796,803 | May 15, 2026 |
| Bellevue Group AG | Reduced | 2,788,245 | Aug 14, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 2,766,868 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 2,649,368 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 2,649,368 | Aug 14, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 1,934,286 | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 1,931,884 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 28, 2026